Rachel A. Millstein, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Environment Design | 8 | 2021 | 178 | 1.400 |
Why?
|
| Health Behavior | 13 | 2022 | 2635 | 1.120 |
Why?
|
| Residence Characteristics | 11 | 2021 | 2050 | 1.060 |
Why?
|
| Motor Activity | 10 | 2015 | 2715 | 0.920 |
Why?
|
| Environment | 6 | 2016 | 1123 | 0.880 |
Why?
|
| Exercise | 16 | 2022 | 5615 | 0.860 |
Why?
|
| Patient Compliance | 4 | 2018 | 2684 | 0.720 |
Why?
|
| Behavioral Research | 2 | 2018 | 54 | 0.690 |
Why?
|
| Resilience, Psychological | 3 | 2020 | 677 | 0.660 |
Why?
|
| National Institutes of Health (U.S.) | 4 | 2018 | 780 | 0.620 |
Why?
|
| Behavioral Medicine | 1 | 2018 | 50 | 0.610 |
Why?
|
| Policy | 3 | 2020 | 508 | 0.600 |
Why?
|
| Mind-Body Therapies | 1 | 2020 | 247 | 0.590 |
Why?
|
| Maternal Deprivation | 2 | 2006 | 48 | 0.550 |
Why?
|
| Spouses | 1 | 2018 | 286 | 0.550 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2018 | 262 | 0.540 |
Why?
|
| Acute Coronary Syndrome | 6 | 2020 | 2337 | 0.530 |
Why?
|
| Health Promotion | 6 | 2020 | 2205 | 0.480 |
Why?
|
| Stress, Psychological | 10 | 2021 | 4245 | 0.470 |
Why?
|
| Parents | 4 | 2020 | 3405 | 0.460 |
Why?
|
| Public Facilities | 2 | 2015 | 34 | 0.440 |
Why?
|
| Anxiety | 6 | 2023 | 4293 | 0.440 |
Why?
|
| Social Support | 4 | 2018 | 2118 | 0.430 |
Why?
|
| Sports Equipment | 1 | 2011 | 23 | 0.410 |
Why?
|
| Play and Playthings | 1 | 2011 | 79 | 0.390 |
Why?
|
| Motivation | 1 | 2020 | 1971 | 0.370 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2020 | 11726 | 0.370 |
Why?
|
| Emotions | 4 | 2017 | 2659 | 0.370 |
Why?
|
| Schools | 2 | 2016 | 1433 | 0.360 |
Why?
|
| Depression | 8 | 2020 | 7759 | 0.320 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 5 | 2007 | 322 | 0.310 |
Why?
|
| Mice, Inbred Strains | 2 | 2006 | 1828 | 0.280 |
Why?
|
| Psychotherapy | 4 | 2020 | 1642 | 0.280 |
Why?
|
| Societies, Medical | 1 | 2018 | 3743 | 0.270 |
Why?
|
| City Planning | 2 | 2015 | 13 | 0.260 |
Why?
|
| Body Size | 1 | 2008 | 461 | 0.260 |
Why?
|
| Obesity | 3 | 2016 | 12746 | 0.250 |
Why?
|
| Diet, Reducing | 1 | 2008 | 462 | 0.250 |
Why?
|
| Walking | 5 | 2021 | 1180 | 0.240 |
Why?
|
| Safety | 3 | 2014 | 1186 | 0.240 |
Why?
|
| Pilot Projects | 8 | 2021 | 8319 | 0.240 |
Why?
|
| Food | 1 | 2009 | 772 | 0.230 |
Why?
|
| Personal Satisfaction | 1 | 2008 | 643 | 0.230 |
Why?
|
| Substance-Related Disorders | 5 | 2019 | 4257 | 0.210 |
Why?
|
| Neural Inhibition | 1 | 2006 | 602 | 0.210 |
Why?
|
| Socioeconomic Factors | 6 | 2018 | 7785 | 0.200 |
Why?
|
| Quality of Life | 5 | 2023 | 12802 | 0.200 |
Why?
|
| Mental Health | 5 | 2020 | 3010 | 0.200 |
Why?
|
| Social Environment | 1 | 2006 | 1022 | 0.190 |
Why?
|
| Behavior Therapy | 2 | 2018 | 865 | 0.190 |
Why?
|
| Feeding Behavior | 2 | 2014 | 3188 | 0.190 |
Why?
|
| Program Evaluation | 3 | 2020 | 2488 | 0.180 |
Why?
|
| Veterans | 3 | 2021 | 2519 | 0.180 |
Why?
|
| Qualitative Research | 4 | 2020 | 2682 | 0.170 |
Why?
|
| Psychotherapy, Group | 2 | 2020 | 406 | 0.170 |
Why?
|
| Female | 40 | 2022 | 380193 | 0.170 |
Why?
|
| Research | 3 | 1998 | 1999 | 0.160 |
Why?
|
| Personnel, Hospital | 1 | 2020 | 283 | 0.160 |
Why?
|
| Prisoners | 1 | 2021 | 297 | 0.160 |
Why?
|
| Psychometrics | 2 | 2019 | 3003 | 0.160 |
Why?
|
| Chronic Disease | 4 | 2020 | 9145 | 0.160 |
Why?
|
| Humans | 54 | 2023 | 744366 | 0.150 |
Why?
|
| Happiness | 1 | 2019 | 170 | 0.150 |
Why?
|
| Behavior, Animal | 6 | 2008 | 1881 | 0.150 |
Why?
|
| Middle Aged | 24 | 2020 | 213390 | 0.150 |
Why?
|
| Male | 39 | 2021 | 350115 | 0.150 |
Why?
|
| Individuality | 1 | 2019 | 307 | 0.150 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2023 | 445 | 0.150 |
Why?
|
| Contingent Negative Variation | 1 | 2016 | 34 | 0.150 |
Why?
|
| Heart Diseases | 2 | 2020 | 2789 | 0.140 |
Why?
|
| Weight Loss | 1 | 2008 | 2625 | 0.140 |
Why?
|
| Women's Health | 2 | 2013 | 2034 | 0.140 |
Why?
|
| Genetics, Behavioral | 2 | 2006 | 53 | 0.140 |
Why?
|
| Baltimore | 3 | 2014 | 231 | 0.140 |
Why?
|
| Ethanol | 3 | 2008 | 1342 | 0.140 |
Why?
|
| Hospitals, General | 1 | 2020 | 749 | 0.140 |
Why?
|
| Crime | 2 | 2014 | 215 | 0.130 |
Why?
|
| Central Nervous System Depressants | 2 | 2006 | 167 | 0.130 |
Why?
|
| Adolescent | 11 | 2020 | 85779 | 0.130 |
Why?
|
| Child | 12 | 2020 | 77709 | 0.120 |
Why?
|
| Adaptation, Psychological | 2 | 2020 | 2575 | 0.120 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2014 | 63 | 0.120 |
Why?
|
| Program Development | 1 | 2020 | 1316 | 0.120 |
Why?
|
| Child Advocacy | 1 | 2014 | 50 | 0.120 |
Why?
|
| Aged | 18 | 2021 | 163288 | 0.120 |
Why?
|
| Factor Analysis, Statistical | 1 | 2016 | 977 | 0.120 |
Why?
|
| Species Specificity | 3 | 2006 | 2478 | 0.110 |
Why?
|
| Serotonin | 3 | 2008 | 1017 | 0.110 |
Why?
|
| Depressive Disorder | 1 | 2006 | 3747 | 0.110 |
Why?
|
| Space Perception | 2 | 2015 | 475 | 0.110 |
Why?
|
| Gender Identity | 1 | 2018 | 687 | 0.110 |
Why?
|
| Self Efficacy | 1 | 2016 | 615 | 0.110 |
Why?
|
| Adult | 17 | 2022 | 214052 | 0.110 |
Why?
|
| Perception | 2 | 2020 | 1198 | 0.100 |
Why?
|
| Developmental Disabilities | 1 | 2020 | 1456 | 0.100 |
Why?
|
| Feasibility Studies | 5 | 2020 | 5077 | 0.100 |
Why?
|
| Reference Values | 1 | 2019 | 4982 | 0.100 |
Why?
|
| Transportation | 3 | 2021 | 214 | 0.100 |
Why?
|
| Tobacco Industry | 1 | 2012 | 126 | 0.100 |
Why?
|
| Affect | 1 | 2019 | 1475 | 0.100 |
Why?
|
| Smoke | 1 | 2012 | 227 | 0.100 |
Why?
|
| Models, Psychological | 1 | 2015 | 811 | 0.090 |
Why?
|
| Autistic Disorder | 1 | 2020 | 1185 | 0.090 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2020 | 3658 | 0.090 |
Why?
|
| Data Collection | 2 | 2011 | 3339 | 0.090 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 57776 | 0.090 |
Why?
|
| Washington | 3 | 2015 | 313 | 0.090 |
Why?
|
| Young Adult | 6 | 2019 | 56429 | 0.090 |
Why?
|
| Public Policy | 1 | 2014 | 572 | 0.090 |
Why?
|
| Telephone | 3 | 2020 | 617 | 0.090 |
Why?
|
| United States | 9 | 2020 | 69872 | 0.090 |
Why?
|
| Counseling | 2 | 2018 | 1523 | 0.080 |
Why?
|
| Public Health | 2 | 2019 | 2602 | 0.080 |
Why?
|
| Leisure Activities | 3 | 2015 | 311 | 0.080 |
Why?
|
| Mice, Inbred DBA | 2 | 2006 | 642 | 0.080 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2008 | 64 | 0.080 |
Why?
|
| Desipramine | 1 | 2008 | 184 | 0.080 |
Why?
|
| Independent Living | 1 | 2012 | 568 | 0.080 |
Why?
|
| Conditioning, Operant | 2 | 2006 | 313 | 0.080 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 1832 | 0.070 |
Why?
|
| California | 3 | 2018 | 1402 | 0.070 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 6486 | 0.070 |
Why?
|
| Clinical Protocols | 1 | 2012 | 1461 | 0.070 |
Why?
|
| Receptors, Vasopressin | 1 | 2006 | 112 | 0.070 |
Why?
|
| Urban Health | 1 | 2009 | 547 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2020 | 41005 | 0.070 |
Why?
|
| Reversal Learning | 1 | 2006 | 60 | 0.070 |
Why?
|
| Alcoholic Intoxication | 1 | 2006 | 188 | 0.070 |
Why?
|
| Linear Models | 2 | 2015 | 5953 | 0.060 |
Why?
|
| Diet | 3 | 2022 | 7937 | 0.060 |
Why?
|
| Discrimination Learning | 1 | 2006 | 280 | 0.060 |
Why?
|
| Limbic System | 1 | 2007 | 426 | 0.060 |
Why?
|
| District of Columbia | 2 | 2014 | 157 | 0.060 |
Why?
|
| Maternal Behavior | 1 | 2006 | 311 | 0.060 |
Why?
|
| Behavioral Symptoms | 1 | 2005 | 175 | 0.060 |
Why?
|
| Extinction, Psychological | 1 | 2007 | 376 | 0.060 |
Why?
|
| Telemedicine | 1 | 2020 | 2872 | 0.060 |
Why?
|
| Social Isolation | 1 | 2006 | 365 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 8 | 2008 | 21833 | 0.060 |
Why?
|
| Antidepressive Agents | 2 | 2020 | 2838 | 0.050 |
Why?
|
| Acoustic Stimulation | 1 | 2006 | 1216 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5445 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2006 | 6542 | 0.050 |
Why?
|
| Poverty | 1 | 1992 | 2660 | 0.040 |
Why?
|
| Nortriptyline | 1 | 2000 | 81 | 0.040 |
Why?
|
| Social Class | 1 | 2009 | 1997 | 0.040 |
Why?
|
| Consumer Advocacy | 1 | 2020 | 81 | 0.040 |
Why?
|
| Mice | 10 | 2008 | 81201 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2006 | 1431 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 4639 | 0.040 |
Why?
|
| Dopamine | 1 | 2006 | 1591 | 0.040 |
Why?
|
| Aging | 2 | 2018 | 8664 | 0.040 |
Why?
|
| Prognosis | 1 | 2019 | 29060 | 0.040 |
Why?
|
| Fear | 1 | 2007 | 1440 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 19905 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 39052 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 12244 | 0.040 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2000 | 434 | 0.040 |
Why?
|
| Mice, Knockout | 6 | 2007 | 14561 | 0.040 |
Why?
|
| Disabled Children | 1 | 2020 | 247 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 6386 | 0.040 |
Why?
|
| Alcohol Drinking | 2 | 2006 | 3966 | 0.040 |
Why?
|
| Overweight | 1 | 2008 | 2371 | 0.040 |
Why?
|
| Meditation | 1 | 2020 | 242 | 0.040 |
Why?
|
| Loneliness | 1 | 2018 | 185 | 0.040 |
Why?
|
| Animals | 12 | 2008 | 168768 | 0.040 |
Why?
|
| Retirement | 1 | 2018 | 216 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2020 | 692 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2016 | 6459 | 0.030 |
Why?
|
| Smoking | 1 | 2012 | 8987 | 0.030 |
Why?
|
| Health Facilities | 1 | 2020 | 572 | 0.030 |
Why?
|
| Exploratory Behavior | 2 | 2006 | 270 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2008 | 10943 | 0.030 |
Why?
|
| Body Temperature | 2 | 2008 | 777 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 3020 | 0.030 |
Why?
|
| Analysis of Variance | 3 | 2008 | 6366 | 0.030 |
Why?
|
| Hippocampus | 1 | 2006 | 3675 | 0.030 |
Why?
|
| Heart Failure | 1 | 2017 | 10895 | 0.030 |
Why?
|
| Cities | 1 | 2015 | 513 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2015 | 281 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2016 | 1590 | 0.030 |
Why?
|
| Bicycling | 1 | 2014 | 176 | 0.030 |
Why?
|
| Sex Factors | 2 | 2014 | 10400 | 0.030 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 1997 | 615 | 0.030 |
Why?
|
| Brain Chemistry | 2 | 2006 | 982 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2005 | 3646 | 0.030 |
Why?
|
| Self Medication | 1 | 2012 | 117 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 1425 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2022 | 2063 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2008 | 12721 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2006 | 18034 | 0.020 |
Why?
|
| HIV Infections | 2 | 1998 | 16715 | 0.020 |
Why?
|
| Fenclonine | 1 | 2008 | 16 | 0.020 |
Why?
|
| Phenotype | 1 | 2006 | 16367 | 0.020 |
Why?
|
| Research Design | 2 | 2017 | 5984 | 0.020 |
Why?
|
| Family | 1 | 2020 | 3147 | 0.020 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 5321 | 0.020 |
Why?
|
| Adrenergic Agents | 1 | 2008 | 70 | 0.020 |
Why?
|
| Peer Group | 1 | 2012 | 635 | 0.020 |
Why?
|
| Sleep | 3 | 2008 | 4622 | 0.020 |
Why?
|
| Caregivers | 1 | 2018 | 2095 | 0.020 |
Why?
|
| Demography | 1 | 1992 | 1655 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2013 | 2373 | 0.020 |
Why?
|
| Fluvoxamine | 1 | 2006 | 74 | 0.020 |
Why?
|
| Self Report | 1 | 2017 | 3553 | 0.020 |
Why?
|
| Electrochemistry | 1 | 2006 | 145 | 0.020 |
Why?
|
| Educational Status | 1 | 2014 | 2540 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2006 | 153 | 0.020 |
Why?
|
| Risk-Taking | 1 | 1992 | 986 | 0.020 |
Why?
|
| Hindlimb Suspension | 1 | 2006 | 83 | 0.020 |
Why?
|
| Tritium | 1 | 2006 | 745 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2008 | 909 | 0.020 |
Why?
|
| Swimming | 1 | 2006 | 205 | 0.020 |
Why?
|
| Income | 1 | 2014 | 1913 | 0.020 |
Why?
|
| Body Temperature Regulation | 1 | 2006 | 252 | 0.020 |
Why?
|
| Hypothermia | 1 | 2006 | 189 | 0.020 |
Why?
|
| Maze Learning | 1 | 2007 | 478 | 0.020 |
Why?
|
| Reflex | 1 | 2006 | 365 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2006 | 291 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2008 | 1794 | 0.010 |
Why?
|
| Dendrites | 1 | 2007 | 485 | 0.010 |
Why?
|
| Benzazepines | 1 | 2006 | 326 | 0.010 |
Why?
|
| Rodentia | 1 | 2005 | 261 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2015 | 4576 | 0.010 |
Why?
|
| Dopamine Agonists | 1 | 2006 | 355 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 9955 | 0.010 |
Why?
|
| Citalopram | 1 | 2006 | 403 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2015 | 10252 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 1572 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2018 | 8551 | 0.010 |
Why?
|
| Postural Balance | 1 | 2006 | 620 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 29786 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2006 | 1958 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 1997 | 5027 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 2887 | 0.010 |
Why?
|
| Risk Factors | 2 | 2015 | 72296 | 0.010 |
Why?
|
| Reward | 1 | 2006 | 940 | 0.010 |
Why?
|
| Reaction Time | 1 | 2006 | 2098 | 0.010 |
Why?
|
| Brain | 1 | 2006 | 26388 | 0.010 |
Why?
|
| Amygdala | 1 | 2007 | 1315 | 0.010 |
Why?
|
| Hypnotics and Sedatives | 1 | 2006 | 1162 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2006 | 1901 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 5135 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 2007 | 2690 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2006 | 2624 | 0.010 |
Why?
|
| Time Factors | 2 | 2006 | 40075 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2015 | 23336 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 9384 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2006 | 5096 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 25039 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14723 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 40559 | 0.010 |
Why?
|
| Pregnancy | 1 | 1992 | 29144 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 63107 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2000 | 12025 | 0.000 |
Why?
|
| Comorbidity | 1 | 1997 | 10388 | 0.000 |
Why?
|
| Prevalence | 1 | 1997 | 15221 | 0.000 |
Why?
|